Novel combination therapy reduces subconjunctival fibrosis after glaucoma filtration surgery in the rabbit model.

This study demonstrates that IP-10p significantly reduces histological scarring compared to BSS or MMC alone, does not damage the conjunctiva to the extent of current standards, and may be an alternative or adjunct to MMC for those undergoing GFS.